PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab-Reference-Cited by-同舟云学术

PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab

Published:2016-06-22 Issue:9 Volume:13 Page:2923-2940
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Elsaid Naba¹,Jackson Timothy L.²,Elsaid Zeeneh³,Alqathama Aljawharah³,Somavarapu Satyanarayana³

Affiliation:

1. University of Hertfordshire, Hatfield, United Kingdom

2. King’s College London, London, United Kingdom

3. University College London School of Pharmacy, London, United Kingdom

Funder

King’s College Hospital NHS Foundation Trust

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b00335

Reference114 articles.

1. Certifications for sight impairment due to age related macular degeneration in England

2. NICE. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: NICE technology appraisal guidance [TA155]. 2008, [16/05/2016]. Available from:https://www.nice.org.uk/guidance/ta155/chapter/2-Clinical-need-and-practice.

3. Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)

4. Complications of intravitreal injections

5. Qualitätsunterschiede zwischen Ranibizumab aus Originalbehältern und aus Fertigspritzen

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Absorption enhancement strategies in chitosan-based nanosystems and hydrogels intended for ocular delivery: Latest advances for optimization of drug permeation;Carbohydrate Polymers;2024-11

2. Advances in ophthalmic therapeutic delivery: A comprehensive overview of present and future directions;Survey of Ophthalmology;2024-11

3. Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective;BioImpacts;2024-05-19

4. In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye;Drug Delivery and Translational Research;2024-03-22

5. Biopolymers for in situ–forming hydrogels, synthesis, characterization, toxicity issues, and application;Stimuli-Responsive Hydrogels for Ophthalmic Drug Delivery;2024